ES532537A0 - Un procedimiento para preparar un derivado de carbostirilo - Google Patents

Un procedimiento para preparar un derivado de carbostirilo

Info

Publication number
ES532537A0
ES532537A0 ES532537A ES532537A ES532537A0 ES 532537 A0 ES532537 A0 ES 532537A0 ES 532537 A ES532537 A ES 532537A ES 532537 A ES532537 A ES 532537A ES 532537 A0 ES532537 A0 ES 532537A0
Authority
ES
Spain
Prior art keywords
carbostirile
derivative
preparing
procedure
carbostirile derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532537A
Other languages
English (en)
Other versions
ES8601187A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15409082A external-priority patent/JPS5962585A/ja
Priority claimed from JP57213167A external-priority patent/JPS59104378A/ja
Priority claimed from JP58114679A external-priority patent/JPS606685A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of ES8601187A1 publication Critical patent/ES8601187A1/es
Publication of ES532537A0 publication Critical patent/ES532537A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
ES532537A 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo Granted ES532537A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15409082A JPS5962585A (ja) 1982-09-03 1982-09-03 カルボスチリル誘導体
JP57213167A JPS59104378A (ja) 1982-12-03 1982-12-03 カルボスチリル誘導体
JP58114679A JPS606685A (ja) 1983-06-24 1983-06-24 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
ES8601187A1 ES8601187A1 (es) 1985-10-16
ES532537A0 true ES532537A0 (es) 1985-10-16

Family

ID=27312797

Family Applications (4)

Application Number Title Priority Date Filing Date
ES525346A Granted ES525346A0 (es) 1982-09-03 1983-09-02 Un derivado de carbostirilo.
ES532538A Granted ES532538A0 (es) 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo
ES532537A Granted ES532537A0 (es) 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo
ES532536A Expired ES8505998A1 (es) 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES525346A Granted ES525346A0 (es) 1982-09-03 1983-09-02 Un derivado de carbostirilo.
ES532538A Granted ES532538A0 (es) 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES532536A Expired ES8505998A1 (es) 1982-09-03 1984-05-16 Un procedimiento para preparar un derivado de carbostirilo

Country Status (11)

Country Link
US (1) US4564619A (es)
KR (1) KR910000181B1 (es)
CA (1) CA1252469A (es)
CH (1) CH655110A5 (es)
DE (1) DE3331808A1 (es)
ES (4) ES525346A0 (es)
FR (1) FR2532648B1 (es)
GB (1) GB2127402B (es)
IT (1) IT1193145B (es)
NL (1) NL8303066A (es)
SE (1) SE455503B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
KR940000785B1 (ko) * 1986-04-02 1994-01-31 오오쓰까세이야꾸 가부시끼가이샤 카르보스티릴 유도체 및 그의 염의 제조 방법
KR100305515B1 (ko) * 1999-02-04 2001-09-24 이순금 메주의 제조방법
NL1012886C1 (nl) 1999-08-23 2001-02-26 Rephartox 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan.
KR100422242B1 (ko) * 2001-07-20 2004-03-12 농업회사법인(주)맛가마식품 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
RU2005110062A (ru) * 2002-10-07 2006-01-10 Артезиан Терапьютикс, Инк. (US) Дигидропиридиновые соединения, обладающие одновременной способностью к блокированию кальциевых каналов l-типа и к ингибированию активности фосфодиэстеразы типа 3
NL1028564C2 (nl) * 2005-03-17 2006-09-20 Rademaker Holding B V Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten.
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007223036A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2026813A2 (en) * 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971797A (en) * 1973-06-15 1976-07-27 Merck & Co., Inc. S,S'-bis(pyridylmethyl)-carbonodithioates
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2659665A1 (de) * 1976-12-30 1978-07-13 Nattermann A & Cie Neue 1,4-dihydropyridin-derivate
JPS5387368A (en) * 1977-01-12 1978-08-01 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5390270A (en) * 1977-01-14 1978-08-08 Otsuka Pharmaceut Co Ltd Carbostryl derivs.
NZ187452A (en) * 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
IT1097538B (it) * 1978-07-17 1985-08-31 Medea Res Srl Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS57200386A (en) * 1981-06-04 1982-12-08 Yoshitomi Pharmaceut Ind Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts

Also Published As

Publication number Publication date
SE8304737L (sv) 1984-03-04
ES8506697A1 (es) 1985-07-16
CA1252469A (en) 1989-04-11
IT1193145B (it) 1988-06-02
ES8601187A1 (es) 1985-10-16
IT8367922A0 (it) 1983-09-05
KR850000402A (ko) 1985-02-27
FR2532648B1 (fr) 1989-07-21
ES8502686A1 (es) 1985-01-16
ES532536A0 (es) 1985-06-16
GB8323542D0 (en) 1983-10-05
ES532538A0 (es) 1985-07-16
FR2532648A1 (fr) 1984-03-09
US4564619A (en) 1986-01-14
SE8304737D0 (sv) 1983-09-02
ES8505998A1 (es) 1985-06-16
SE455503B (sv) 1988-07-18
KR910000181B1 (ko) 1991-01-21
NL8303066A (nl) 1984-04-02
GB2127402B (en) 1987-01-14
DE3331808A1 (de) 1984-03-08
CH655110A5 (de) 1986-03-27
ES525346A0 (es) 1985-01-16
GB2127402A (en) 1984-04-11

Similar Documents

Publication Publication Date Title
ES530716A0 (es) Un procedimiento de preparacion de un derivado de carbostirilo
ES532538A0 (es) Un procedimiento para preparar un derivado de carbostirilo
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES527790A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES534297A0 (es) Un procedimiento para preparar derivados de cefem
ES523419A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES530017A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES526088A0 (es) Un procedimiento para preparar derivados de ciclobutano
ES527237A0 (es) Un procedimiento para producir derivados de tiazol
ES525099A0 (es) Procedimiento de preparacion de un derivado de la benzamida
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES534356A0 (es) Un metodo para preparar derivados de fenotiazina
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES527738A0 (es) Un procedimiento para preparar derivados de piridona
ES527108A0 (es) Un procedimiento para preparar 2-alcoxi-5-(piridinil) piridinas
ES527789A0 (es) Un procedimiento para preparar derivados de cicloalquenilo
ES525647A0 (es) Un procedimiento para preparar compuestos de benzoilurea
ES518376A0 (es) Un procedimiento para preparar nuevas nitro-n-fenilpiridinaminas
ES520407A0 (es) Un procedimiento para preparar un derivado de 3-azetidiniletil-1-fenil-2-imidazolidinona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303